These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11853668)

  • 1. Specific ablation of Stat3beta distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock.
    Yoo JY; Huso DL; Nathans D; Desiderio S
    Cell; 2002 Feb; 108(3):331-44. PubMed ID: 11853668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional differences between Stat3alpha and Stat3beta.
    Schaefer TS; Sanders LK; Park OK; Nathans D
    Mol Cell Biol; 1997 Sep; 17(9):5307-16. PubMed ID: 9271408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome-wide analysis of the acute-phase response and its regulation by Stat3beta.
    Desiderio S; Yoo JY
    Ann N Y Acad Sci; 2003 Apr; 987():280-4. PubMed ID: 12727653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stat3 and G-CSF-induced myeloid differentiation.
    Chakraborty A; Tweardy DJ
    Leuk Lymphoma; 1998 Aug; 30(5-6):433-42. PubMed ID: 9711905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription.
    Caldenhoven E; van Dijk TB; Solari R; Armstrong J; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP
    J Biol Chem; 1996 May; 271(22):13221-7. PubMed ID: 8675499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective STAT3-α or -β expression reveals spliceform-specific phosphorylation kinetics, nuclear retention and distinct gene expression outcomes.
    Ng IH; Ng DC; Jans DA; Bogoyevitch MA
    Biochem J; 2012 Oct; 447(1):125-36. PubMed ID: 22799634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of a constitutively active Stat3 protein.
    Barboza JA; Wang S; Schaefer TS
    Mol Biol Rep; 2004 Mar; 31(1):13-21. PubMed ID: 15040450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimer stability as a determinant of differential DNA binding activity of Stat3 isoforms.
    Park OK; Schaefer LK; Wang W; Schaefer TS
    J Biol Chem; 2000 Oct; 275(41):32244-9. PubMed ID: 10915797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3beta, a distinct isoform from STAT3.
    Zhang HX; Yang PL; Li EM; Xu LY
    Int J Biochem Cell Biol; 2019 May; 110():130-139. PubMed ID: 30822557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Src activates the DNA binding and transcriptional activity of Stat3 molecules: serine 727 is not required for transcriptional activation under certain circumstances.
    Schaefer LK; Wang S; Schaefer TS
    Biochem Biophys Res Commun; 1999 Dec; 266(2):481-7. PubMed ID: 10600528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCBP1 inhibits the expression of oncogenic STAT3 isoform by targeting alternative splicing of STAT3 exon 23.
    Wang X; Guo J; Che X; Jia R
    Int J Biol Sci; 2019; 15(6):1177-1186. PubMed ID: 31223278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel missense (M206K) STAT3 mutation in diffuse large B cell lymphoma deregulates STAT3 signaling.
    Hu G; Witzig TE; Gupta M
    PLoS One; 2013; 8(7):e67851. PubMed ID: 23861822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Entinostat as a Novel Modifier of STAT3 Pre-mRNA Alternative Splicing.
    Kise M; Masaki S; Kataoka N; Suzuki K
    Biol Pharm Bull; 2024; 47(9):1504-1510. PubMed ID: 39284734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stat3 isoforms, alpha and beta, demonstrate distinct intracellular dynamics with prolonged nuclear retention of Stat3beta mapping to its unique C-terminal end.
    Huang Y; Qiu J; Dong S; Redell MS; Poli V; Mancini MA; Tweardy DJ
    J Biol Chem; 2007 Nov; 282(48):34958-67. PubMed ID: 17855361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stat3 activation by Src induces specific gene regulation and is required for cell transformation.
    Turkson J; Bowman T; Garcia R; Caldenhoven E; De Groot RP; Jove R
    Mol Cell Biol; 1998 May; 18(5):2545-52. PubMed ID: 9566874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer.
    Bharadwaj U; Kasembeli MM; Eckols TK; Kolosov M; Lang P; Christensen K; Edwards DP; Tweardy DJ
    Cancers (Basel); 2014 Sep; 6(4):2012-34. PubMed ID: 25268166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stat3β mitigates development of atherosclerosis in apolipoprotein E-deficient mice.
    Lee J; Baldwin WM; Lee CY; Desiderio S
    J Mol Med (Berl); 2013 Aug; 91(8):965-76. PubMed ID: 23619910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 2 and 15 activate Stat3alpha in human T lymphocytes.
    Nielsen M; Nordahl M; Svejgaard A; Odum N
    Cytokine; 1998 Oct; 10(10):735-8. PubMed ID: 9811525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumorigenic potential of STAT3 alternative splicing modulation.
    Zammarchi F; de Stanchina E; Bournazou E; Supakorndej T; Martires K; Riedel E; Corben AD; Bromberg JF; Cartegni L
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17779-84. PubMed ID: 22006329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligonucleotide-directed STAT3 alternative splicing switch drives anti-tumorigenic outcomes in MCF10 human breast cancer cells.
    Tano V; Jans DA; Bogoyevitch MA
    Biochem Biophys Res Commun; 2019 Jun; 513(4):1076-1082. PubMed ID: 31010684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.